Trump's Health Picks: Balancing Politics, Science, and Pharma Interests
TL;DR Summary
Drug companies are encountering hostility as they seek support from President Trump's health appointees. The pharmaceutical industry is hoping to find allies within the new administration to influence health policy and regulation in their favor.
Topics:nation#drug-companies#health#health-policy#pharmaceutical-industry#regulation#trump-administration
- Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks The New York Times
- How Will Trump’s Covid Contrarians Handle the Next Pandemic? The New York Times
- Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say CNBC
- One major challenge facing Trump’s chosen health leaders: Keeping politics separate from science CNN
- 4 takeaways from Trump’s health agency nominations The Hill
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
-21%
29 → 35 words
Want the full story? Read the original article
Read on The New York Times